Coya Therapeutics, Inc.
COYA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$14,881 | -$7,988 | -$12,245 | -$4,892 |
| Dep. & Amort. | $27 | $27 | $27 | $16 |
| Deferred Tax | $0 | $0 | $0 | $400 |
| Stock-Based Comp. | $2,664 | $872 | $207 | $233 |
| Change in WC | $1,876 | -$4,644 | $752 | $739 |
| Other Non-Cash | $25 | $543 | $4,019 | -$400 |
| Operating Cash Flow | -$10,289 | -$11,189 | -$7,239 | -$3,903 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$137 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$25 | -$543 | -$525 | $0 |
| Investing Cash Flow | -$25 | -$543 | -$525 | -$137 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $10,469 | $0 |
| Stock Issued | $14,004 | $38,335 | $0 | $1 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2,022 | $90 | -$1,111 | -$342 |
| Financing Cash Flow | $16,027 | $38,425 | $9,358 | -$341 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $5,713 | $26,693 | $1,594 | -$4,381 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $32,627 | $5,934 | $4,340 | $8,721 |
| End Cash | $38,340 | $32,627 | $5,934 | $4,340 |
| Free Cash Flow | -$10,289 | -$11,189 | -$7,239 | -$4,040 |